![](/img/cover-not-exists.png)
B28Safety of Lanreotide 120 mg ATG in combination with metformin in patients with progressive advanced well-differentiated gastro-intestinal (GI) or lung carcinoids. A pilot, one-arm, open-label, prospective study: the MetNET-2 trial
Buzzoni, R., Filippo, D.B., Femia, D., Prinzi, N., Concas, L., Milione, M., Tamborini, E., Perrone, F., Lo Russo, G., Vernieri, C., Pulice, I., Piras, F., Dinoi, G., Pusceddu, S.Volume:
27
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw333.28
Date:
September, 2016
File:
PDF, 63 KB
2016